These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17035001)

  • 1. Transforming-growth factor beta1 Leu10Pro polymorphism and breast cancer morbidity.
    González-Zuloeta Ladd AM; Arias-Vásquez A; Siemes C; Coebergh JW; Hofman A; Witteman J; Uitterlinden A; Stricker BH; van Duijn CM
    Eur J Cancer; 2007 Jan; 43(2):371-4. PubMed ID: 17035001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential roles of Angiotensinogen and Angiotensin Receptor type 1 polymorphisms in breast cancer risk.
    González-Zuloeta Ladd AM; Arias Vásquez A; Siemes C; Yazdanpanah M; Coebergh JW; Hofman A; Stricker BH; van Duijn CM
    Breast Cancer Res Treat; 2007 Mar; 101(3):299-304. PubMed ID: 16823505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T29C polymorphism in the transforming growth factor beta1 gene and postmenopausal breast cancer risk: the Multiethnic Cohort Study.
    Le Marchand L; Haiman CA; van den Berg D; Wilkens LR; Kolonel LN; Henderson BE
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):412-5. PubMed ID: 15006917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in transforming growth factor-beta1 gene associated with increased risk of esophageal squamous cell carcinoma.
    Wei YS; Xu QQ; Wang CF; Pan Y; Liang F; Long XK
    Tissue Antigens; 2007 Dec; 70(6):464-9. PubMed ID: 17990985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme gene insertion/deletion polymorphism and breast cancer risk.
    González-Zuloeta Ladd AM; Arias Vásquez A; Sayed-Tabatabaei FA; Coebergh JW; Hofman A; Njajou O; Stricker B; van Duijn C
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2143-6. PubMed ID: 16172223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms of the transforming growth factor-beta1 gene and breast cancer risk: a possible dual role at different cancer stages.
    Shin A; Shu XO; Cai Q; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1567-70. PubMed ID: 15941974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-1 CA repeat variant and breast cancer risk in postmenopausal women.
    González-Zuloeta Ladd AM; Liu F; Houben MP; Arias Vásquez A; Siemes C; Janssens AC; Coebergh JW; Hofman A; Janssen JA; Stricker BH; van Duijn CM
    Eur J Cancer; 2007 Jul; 43(11):1718-22. PubMed ID: 17561390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a TGF-β1 gene -509 C/T polymorphism with breast cancer risk: a meta-analysis.
    Woo SU; Park KH; Woo OH; Yang DS; Kim AR; Lee ES; Lee JB; Kim YH; Kim JS; Seo JH
    Breast Cancer Res Treat; 2010 Nov; 124(2):481-5. PubMed ID: 20361250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of common transforming growth factor beta-1 gene polymorphisms in gastric and duodenal ulcer disease: pilot study.
    Polonikov AV; Ivanov VP; Belugin DA; Khoroshaya IV; Kolchanova IO; Solodilova MA; Tutochkina MP; Stepchenko AA
    J Gastroenterol Hepatol; 2007 Apr; 22(4):555-64. PubMed ID: 17376051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma.
    Wei YS; Zhu YH; Du B; Yang ZH; Liang WB; Lv ML; Kuang XH; Tai SH; Zhao Y; Zhang L
    Clin Chim Acta; 2007 May; 380(1-2):165-9. PubMed ID: 17368597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β1 29T/C polymorphism and breast cancer risk: a meta-analysis involving 25,996 subjects.
    Huang Y; Li B; Qian J; Xie J; Yu L
    Breast Cancer Res Treat; 2010 Oct; 123(3):863-8. PubMed ID: 20845106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene polymorphism in transforming growth factor-beta codon 10 is associated with susceptibility to Giardiasis.
    Taherkhani H; Hajilooi M; Fallah M; Khyabanchi O; Haidari M
    Int J Immunogenet; 2009 Dec; 36(6):345-9. PubMed ID: 19703231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
    Papadopoulou E; Anagnostopoulos K; Tripsianis G; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
    Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of transforming growth factor beta-1 gene polymorphisms C-509T and T869C and the risk of gastric cancer in China.
    Li T; Cao BW; Dai Y; Cui H; Yang HL; Xu CQ
    J Gastroenterol Hepatol; 2008 Apr; 23(4):638-42. PubMed ID: 18341540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma.
    Crivello A; Giacalone A; Vaglica M; Scola L; Forte GI; Macaluso MC; Raimondi C; Di Noto L; Bongiovanni A; Accardo A; Candore G; Palmeri L; Verna R; Caruso C; Lio D; Palmeri S
    Ann N Y Acad Sci; 2006 Nov; 1089():98-103. PubMed ID: 17261758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human epithelial growth factor receptor 2[Ile655Val] polymorphism and risk of breast fibroadenoma.
    Zubor P; Kajo K; Stanclova A; Szunyogh N; Galo S; Dussan CA; Minarik G; Visnovsky J; Danko J
    Eur J Cancer Prev; 2008 Feb; 17(1):33-8. PubMed ID: 18090908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
    Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
    Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The G/G genotype of transforming growth factor beta 1 (TGF-beta1) single nucleotide (+915G/C) polymorphism coincident with other host and environmental factors is associated with irreversible bronchoconstriction in asthmatics.
    Liebhart J; Polak M; Dabrowski A; Dobek R; Liebhart E; Dor-Wojnarowska A; Barg W; Kulczak A; Medrala W; Gladysz U; Lange A
    Int J Immunogenet; 2008 Dec; 35(6):417-22. PubMed ID: 19046298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER-2/neu Ile655Val polymorphism and the risk of breast cancer.
    Siddig A; Mohamed AO; Kamal H; Awad S; Hassan AH; Zilahi E; Al-Haj M; Bernsen R; Adem A
    Ann N Y Acad Sci; 2008 Sep; 1138():84-94. PubMed ID: 18837888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels and genetic variation of TGF-beta1 are not associated with Alzheimer's disease.
    Rodríguez-Rodríguez E; Sánchez-Juan P; Mateo I; Llorca J; Infante J; García-Gorostiaga I; Berciano J; Combarros O
    Acta Neurol Scand; 2007 Dec; 116(6):409-12. PubMed ID: 17986101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.